24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Timely and spatially regulated maturation of B and T cell repertoire during human fetal development.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Insights into the ontogeny of the human fetal adaptive immune system are of great value for understanding immunocompetence of the developing fetus. However, to date, this has remained largely uncharted territory, in large part because blood samples from healthy, early gestation fetuses have been hard to come by. In a comprehensive study, we analyzed levels of T cell receptor excision circles (TRECs), signal-joint κ receptor excision circles (sjKRECs), and intron recombination signal sequence-K-deleting element (iRSS-Kde) rearrangement, and T and B lymphocyte repertoire clonality in human fetuses from 12 to 26 weeks of gestational age. Using next-generation sequencing, we analyzed the diversity and complexity of T cell receptor β (TRB) and immunoglobulin heavy chain (IGH) repertoires in four fetuses at 12, 13, 22, and 26 weeks of gestation and in healthy full-term infants. We report the progressive increase of TREC, sjKREC, and iRSS-Kde levels over time and confirm that B cell development precedes T cell development in the human fetus. Temporally and spatially regulated maturation of B and T cell repertoire diversity and complexity during human fetal development was observed, including evidence that immunoglobulin somatic hypermutation and class switch recombination occur already during intrauterine life. Our results help define physiological levels of immunodeficiency in premature infants and may serve as a reference for future studies aimed at investigating the impact of intrauterine pathologies on fetal immune development and function.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.

          J. Xu, M Davis (2000)
          All rearranging antigen receptor genes have one or two highly diverse complementarity determining regions (CDRs) among the six that typically form the ligand binding surface. We report here that, in the case of antibodies, diversity at one of these regions, CDR3 of the V(H) domain, is sufficient to permit otherwise identical IgM molecules to distinguish between a variety of hapten and protein antigens. Furthermore, we find that somatic mutation can allow such antibodies to achieve surprisingly high affinities. These results are consistent with a model in which the highly diverse CDR3 loops are the key determinant of specificity in antigen recognition in both T cell receptors (TCR) and antibodies, whereas the germline-encoded CDR1 and CDR2 sequences are much more cross-reactive.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Challenges in infant immunity: implications for responses to infection and vaccines.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The development of the immune system during pregnancy and early life.

                Bookmark

                Author and article information

                Journal
                Sci Transl Med
                Science translational medicine
                1946-6242
                1946-6234
                Feb 25 2015
                : 7
                : 276
                Affiliations
                [1 ] Pediatric Immunology Unit, Jeffrey Modell Foundation Center, and Department of Pediatrics, the Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 5262100, Israel.
                [2 ] Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA 02459, USA.
                [3 ] Pediatric Immunology Unit, Jeffrey Modell Foundation Center, and Department of Pediatrics, the Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 5262100, Israel. Hematology Laboratory, Cancer Research Center, Sheba Medical Center, Tel Hashomer 5262100, Israel.
                [4 ] Department of Obstetrics and Gynecology, Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 5262100, Israel.
                [5 ] Hematology Laboratory, Cancer Research Center, Sheba Medical Center, Tel Hashomer 5262100, Israel.
                [6 ] Department of Obstetrics and Gynecology, Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 5262100, Israel. boaz.weisz@sheba.health.gov.il luigi.notarangelo@childrens.harvard.edu raz.somech@sheba.health.gov.il.
                [7 ] Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA 02459, USA. The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA 02459, USA. Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA. boaz.weisz@sheba.health.gov.il luigi.notarangelo@childrens.harvard.edu raz.somech@sheba.health.gov.il.
                [8 ] Pediatric Immunology Unit, Jeffrey Modell Foundation Center, and Department of Pediatrics, the Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 5262100, Israel. boaz.weisz@sheba.health.gov.il luigi.notarangelo@childrens.harvard.edu raz.somech@sheba.health.gov.il.
                Article
                7/276/276ra25
                10.1126/scitranslmed.aaa0072
                25717098
                fccc59fb-7ff8-4d09-8f52-d40a5746d8d1
                Copyright © 2015, American Association for the Advancement of Science.
                History

                Comments

                Comment on this article